icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy 		Back grey_arrow_rt.gif
 
 
 
Efficacy of elafibranor in primary biliary cholangitis: Results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial
 
 
 

0619241

0619242

0619243

0619244